NovoSeven (recombinant activated factor VII)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NovoSeven (recombinant activated factor VII), covering 2016-05-13 to 2016-05-13. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Mode of Action of a Single Dose and Multiple Doses of Long Acting Activated Recombinant Human Factor VII in Patients With Haemophilia A and B [Phase 1]